United Therapeutics (UTHR) Competitors

Alnylam Pharmaceuticals (NASDAQ:ALNY) and United Therapeutics (NASDAQ:UTHR) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, earnings, dividends, profitability, valuation and risk.

Do insiders and institutionals have more ownership in ALNY or UTHR?

93.0% of Alnylam Pharmaceuticals shares are held by institutional investors. Comparatively, 94.1% of United Therapeutics shares are held by institutional investors. 1.2% of Alnylam Pharmaceuticals shares are held by insiders. Comparatively, 10.3% of United Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Is ALNY or UTHR more profitable?

United Therapeutics has a net margin of 40.36% compared to Alnylam Pharmaceuticals' net margin of -12.96%. United Therapeutics' return on equity of 18.73% beat Alnylam Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alnylam Pharmaceuticals	-12.96%	-273.52%	-7.39%
United Therapeutics	40.36%	18.73%	16.49%

Do analysts rate ALNY or UTHR?

Alnylam Pharmaceuticals presently has a consensus price target of $439.58, indicating a potential downside of 4.10%. United Therapeutics has a consensus price target of $438.85, indicating a potential upside of 0.02%. Given United Therapeutics' higher possible upside, analysts clearly believe United Therapeutics is more favorable than Alnylam Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alnylam Pharmaceuticals	0 Sell rating(s)	4 Hold rating(s)	24 Buy rating(s)	0 Strong Buy rating(s)	2.86
United Therapeutics	0 Sell rating(s)	4 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.69

Which has more volatility & risk, ALNY or UTHR?

Alnylam Pharmaceuticals has a beta of 0.32, meaning that its stock price is 68% less volatile than the S&P 500. Comparatively, United Therapeutics has a beta of 0.62, meaning that its stock price is 38% less volatile than the S&P 500.

Does the media prefer ALNY or UTHR?

In the previous week, United Therapeutics had 3 more articles in the media than Alnylam Pharmaceuticals. MarketBeat recorded 29 mentions for United Therapeutics and 26 mentions for Alnylam Pharmaceuticals. United Therapeutics' average media sentiment score of 0.79 beat Alnylam Pharmaceuticals' score of 0.70 indicating that United Therapeutics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alnylam Pharmaceuticals	10 Very Positive mention(s)	2 Positive mention(s)	10 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
United Therapeutics	18 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has higher earnings and valuation, ALNY or UTHR?

United Therapeutics has higher revenue and earnings than Alnylam Pharmaceuticals. Alnylam Pharmaceuticals is trading at a lower price-to-earnings ratio than United Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alnylam Pharmaceuticals	$2.25B	26.72	-$278.16M	-$2.47	-185.57
United Therapeutics	$3.08B	6.43	$1.20B	$25.62	17.13

Summary

United Therapeutics beats Alnylam Pharmaceuticals on 13 of the 16 factors compared between the two stocks.